AMFEX
Price
$18.58
Change
-$0.18 (-0.96%)
Updated
Jun 13 closing price
Net Assets
382.45M
VSTSX
Price
$281.43
Change
-$3.33 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

AMFEX vs VSTSX

Header iconAMFEX vs VSTSX Comparison
Open Charts AMFEX vs VSTSXBanner chart's image
AAMA Equity
Price$18.58
Change-$0.18 (-0.96%)
VolumeN/A
Net Assets382.45M
Vanguard Total Stock Mkt Idx Instl Sel
Price$281.43
Change-$3.33 (-1.17%)
VolumeN/A
Net Assets1.82T
AMFEX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMFEX vs. VSTSX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFEX is a Buy and VSTSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.82T vs. AMFEX (382M). VSTSX pays higher dividends than AMFEX: VSTSX (1.29) vs AMFEX (0.83). AMFEX was incepted earlier than VSTSX: AMFEX (8 years) vs VSTSX (9 years). AMFEX (1.17) is less costly to investors than VSTSX (0.01). AMFEX is a more actively managed with annual turnover of: 3.00 vs. VSTSX (2.00). AMFEX has a lower initial minimum investment than VSTSX: AMFEX (10000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 10.09 vs. AMFEX (2.76). VSTSX return over 5 years is better than : 91.51 vs. AMFEX (61.52).
AMFEXVSTSXAMFEX / VSTSX
Total Expense Ratio1.170.0111,700%
Annual Report Gross Expense Ratio1.170.0111,700%
Fund Existence8 years9 years-
Gain YTD4.6881.376341%
Front LoadN/AN/A-
Min. Initial Investment1000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets382M1.82T0%
Annual Yield % from dividends0.831.2964%
Returns for 1 year2.7610.0927%
Returns for 3 years30.5157.7053%
Returns for 5 years61.5291.5167%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMOPX34.12N/A
N/A
Patient Opportunity C
SESGX23.52N/A
N/A
Sit ESG Growth S
WPGSX10.29N/A
N/A
WPG Partners Select Small Cap Value Ins
OANBX36.54-0.34
-0.92%
Oakmark Equity and Income Institutional
FCUIX19.08-0.28
-1.45%
NYLI PineStone U.S. Equity Class I